Single jab will offer ‘protective bubble' to premature babies this winter
Experts say the drug will give thousands of vulnerable infants 'their own suit of armour' for their first winter.
From late September, the health service will offer nirsevimab to protect babies born before 32 weeks against respiratory syncytial virus (RSV).
The jab, which offers six months protection in a single dose, will replace monthly injections of palivizumab previously offered.
RSV is a common cause of coughs and colds and usually gets better by itself, but can cause severe illness for babies and older adults.
It is estimated that about 30,000 youngsters are admitted to hospital with the virus every year in the UK, with about 30 babies dying.
According to NHS England, data shows premature babies are three times more likely to go to hospital with RSV and are 10 times more likely to need intensive care when compared to full-term babies.
Health systems in Scotland, Wales and Northern Ireland will also offer nirsevimab from autumn, meaning about 9,000 babies in the UK are set to benefit.
Dr Claire Fuller, co-national medical director for NHS England said: 'This injection will provide premature babies with a protective bubble against RSV just in time for the colder months.
'It will offer a long-lasting defence helping to avoid unnecessary hospitalisations and serious illness – giving babies the best possible start in life and shielding them from harm.'
Since September 2024, pregnant women have been eligible for an RSV jab from 28 weeks onwards to boost their immune system and pass antibodies to their unborn babies to protect them in the first weeks of life.
However, this new drug works differently to the jab, as premature babies born before 32 weeks have limited or no protection given from the vaccinations recommended for pregnant women.
Dr Conall Watson, consultant epidemiologist at the UK Health Security Agency, said: 'Having an RSV vaccine from week 28 in every pregnancy is key to protecting your baby against RSV bronchiolitis. Most RSV hospital admissions in babies can be prevented by vaccination.
'This new NHS nirsevimab immunisation programme will offer really important protection for very premature babies born before they can be protected by mum's antenatal vaccination.'
John Stewart, director of specialised commissioning at NHS England said: 'For babies born very prematurely, the risk of contracting RSV in their first winter is high and extremely serious.
'This new medication will provide vulnerable infants with their own suit of armour that protects against what can be a life-threatening infection.'
Public health minister Ashley Dalton said: 'By rolling out nirsevimab this September, we're ensuring that our most at-risk infants, including those who are born too early to benefit from maternal vaccination, are protected in the best possible way.'
Trial data shows nirsevimab offers more than 80% protection against RSV compared to about 55% with palivizumab, NHS England said.
Nirsevimab will also be offered on a seasonal basis to babies and young children with weakened immune systems or complex heart and lung conditions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
UnitedHealth Group reports mixed second quarter earnings, highest MLR ever
UnitedHealth Group (UNH) reported second quarter earnings Tuesday beating Wall Street's expectations on the top line by a small margin, and missing on the bottom line. But its earnings continues a trend of higher-than-expected costs in the industry this quarter. The company reported revenues of $111.6 billion, compared to Wall Street expectations of $111.53 billion, and adjusted earnings per share (EPS) of $4.08, compared to $4.59 expected by the Street. The company also updated its guidance for the full year, after pulling it last quarter. It now expects revenues between $445.5 to $448.0 billion, and adjust earnings at least $16 per share. UnitedHealth's stock was falling in premarket trading on Tuesday, more than 3% after the earnings report released. Industry pressure More patients seeking care means more premiums being paid out and less revenue for health insurers. Typically, insurers aim to be on the lower end of between 80%-85% of the premiums they receive, known as the medical expense ratio. UnitedHealth reported 89.4% this quarter, compared to 84.8% in the first. That number is the highest in the company's history, breaking its 2024 record of 85.5% — which was attributed to higher utilization of care by seniors. Other insurers have reported 90% or more in the second quarter this year — a significant jump from prior quarters, and it's all related to Medicare or Medicaid programs. The marks a continuing trend, which has been plaguing the industry since last year and has taken several stocks for a ride every quarter. Notably, CVS (CVS) saw a hit to its stock after its Aetna Medicare costs came in higher than expected, but then its stock was boosted last quarter as fears of costs were allayed. This quarter, Centene (CNC) and Elevance (ELV) have faced higher-than-expected costs. The hit to UnitedHealth Tuesday appears to be a delayed part of that trend — and the company has acknowledged it, like other big insurers, is surprised by the hit. Especially with the company's focus on revenue management, owning and acquiring companies over the years that would rely on technology to streamline and increase profits. 'UnitedHealth Group has embarked on a rigorous path back to being a high-performing company fully serving the health needs of individuals and society broadly,' said CEO Stephen Hemsley, in a statement. 'As we strengthen operating disciplines, positioning us for growth in 2026 and beyond, the people at UnitedHealth Group will continue to support the millions of patients, physicians and customers who rely on us, guided by a culture of service and longstanding values.' Industry change In addition to the insurance market woes, UnitedHealth has faced internal struggles. Former CEO Andrew Witty was ousted in May, and former CEO and board chair Stephen Hemsley then took the helm. The executive shakeup came after a year of turmoil for the company, including the largest ever cyberattack on its Change Healthcare subsidiary. Meanwhile, the company is still reeling from the death of insurance executive Brian Thompson, who was shot and killed in New York City last year. The incident prompted an awakening in the insurance industry, which faced a backlash for its system of prior authorization requirements that result in denials of care. Several companies, and the Trump administration, have pledged to fix the problems and relax prior authorization burdens for patients. Humana executives said last week during an earnings call that the company would reduce prior authorizations by one-third of the current volume. United Health previously said that it only sees prior authorizations for 2% of total claims and that it will further reduce that amount. UnitedHealth said Tuesday the company is focused on greater transparency with Hemsley leading, and expects to continue offering greater insight into its operations as it rebuilds the company. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem.
Yahoo
22 minutes ago
- Yahoo
Mountain rescue team called after cyclist breaks ankle in picturesque area
A 50-year-old woman was rescued by the mountain rescue service after breaking her ankle whilst mountain biking in Horwich. Bolton Mountain Rescue Team were called to the scene at 11.27 on Saturday 26 July along with North West Ambulance Service. READ MORE: North West Ambulance Service receive £8m in funding Unison NWAS workers on strike in Bolton over 'lost premia' How North West Ambulance Service is preparing for winter A 50-year-old woman was reported to have broken her ankle whilst mountain biking in Wilderswood, Horwich. Eleven team members of Bolton Mountain Rescue attended and assisted the ambulance crew already on scene. The woman was given pain relief, and her leg was splinted before she was carried for 250m to the waiting ambulance.
Yahoo
22 minutes ago
- Yahoo
UnitedHealth Group reports mixed second quarter earnings; stock down in pre-market trading.
UnitedHealth Group (UNH) reported second quarter earnings Tuesday beating Wall Street's expectations on the top line by a small margin, and missing on the bottom line. But its earnings continues a trend of higher-than-expected costs in the industry this quarter. The company reported revenues of $111.6 billion, compared to Wall Street expectations of $111.53 billion, and adjusted earnings per share (EPS) of $4.08, compared to $4.59 expected by the Street. The revenues are up nearly $13 billion, year-over-year, compared to the second quarter in 2024. But margins have shrunk, from 4.3% in 2024 to 3.1% this quarter. The company also updated its guidance for the full year, after pulling it last quarter. It now expects revenues between $445.5 to $448.0 billion, and adjust earnings at least $16 per share. UnitedHealth's stock was falling in premarket trading on Tuesday, more than 3% after the earnings report released. Industry pressure More patients seeking care means more premiums being paid out and less revenue for health insurers. Typically, insurers aim to be on the lower end of between 80%-85% of the premiums they receive, known as the medical expense ratio. UnitedHealth reported 89.4% this quarter, compared to 84.8% in the first. That number is the highest in the company's history, breaking its 2024 record of 85.5% — which was attributed to higher utilization of care by seniors. Other insurers have reported 90% or more in the second quarter this year — a significant jump from prior quarters, and it's all related to Medicare or Medicaid programs. The marks a continuing trend, which has been plaguing the industry since last year and has taken several stocks for a ride every quarter. Notably, CVS (CVS) saw a hit to its stock after its Aetna Medicare costs came in higher than expected, but then its stock was boosted last quarter as fears of costs were allayed. This quarter, Centene (CNC) and Elevance (ELV) have faced higher-than-expected costs. The hit to UnitedHealth Tuesday appears to be a delayed part of that trend — and the company has acknowledged it, like other big insurers, is surprised by the hit. Especially with the company's focus on revenue management, owning and acquiring companies over the years that would rely on technology to streamline and increase profits. 'UnitedHealth Group has embarked on a rigorous path back to being a high-performing company fully serving the health needs of individuals and society broadly,' said CEO Stephen Hemsley, in a statement. 'As we strengthen operating disciplines, positioning us for growth in 2026 and beyond, the people at UnitedHealth Group will continue to support the millions of patients, physicians and customers who rely on us, guided by a culture of service and longstanding values.' Industry change In addition to the insurance market woes, UnitedHealth has faced internal struggles. Former CEO Andrew Witty was ousted in May, and former CEO and board chair Stephen Hemsley then took the helm. The executive shakeup came after a year of turmoil for the company, including the largest ever cyberattack on its Change Healthcare subsidiary. Meanwhile, the company is still reeling from the death of insurance executive Brian Thompson, who was shot and killed in New York City last year. The incident prompted an awakening in the insurance industry, which faced a backlash for its system of prior authorization requirements that result in denials of care. Several companies, and the Trump administration, have pledged to fix the problems and relax prior authorization burdens for patients. Humana executives said last week during an earnings call that the company would reduce prior authorizations by one-third of the current volume. United Health previously said that it only sees prior authorizations for 2% of total claims and that it will further reduce that amount. UnitedHealth said Tuesday the company is focused on greater transparency with Hemsley leading, and expects to continue offering greater insight into its operations as it rebuilds the company. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
